
Triglimicure 1mg/500mg/15mg Tablet
Marketer
HBC Lifesciences Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Triglimicure 1mg/500mg/15mg Tablet
DiaBetaComb 1mg/500mg/15mg tablets combine medications to effectively manage blood glucose. This formulation, used alongside diet and exercise, improves glycemic control in adult patients with type 2 diabetes. It enhances insulin utilization, consequently reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen for DiaBetaComb 1mg/500mg/15mg tablets. Take with food to minimize gastrointestinal discomfort. If a dose is missed, take it immediately; however, if the next dose is imminent, omit the missed dose and resume your regular schedule. Never double the dose. Overdosage can result in hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol consumption, or meal skipping may increase the risk of hypoglycemia. Regular blood glucose monitoring is essential. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Kidney function tests will be conducted before treatment initiation. Limit alcohol consumption to mitigate the risk of adverse effects.
Uses of Triglimicure 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Triglimicure 1mg/500mg/15mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the Triglimicure 1mg/500mg/15mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Triglimicure 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Triglimicure 1mg/500mg/15mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Triglimicure 1mg/500mg/15mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.
How Triglimicure 1mg/500mg/15mg Tablet works:
Triglimicure 1mg/500mg/15mg tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when monotherapy or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Triglimicure 1mg/500mg/15mg tablets is not advisable.
PregnancyCONSULT YOUR DOCTOR
Using Triglimicure 1mg/500mg/15mg tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Triglimicure 1mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Triglimicure 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Triglimicure 1mg/500mg/15mg tablets are contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Triglimicure 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. Triglimicure 1mg/500mg/15mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Triglimicure 1mg/500mg/15mg Tablet :
Should you forget a Triglimicure 1mg/500mg/15mg Tablet dose, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Triglimicure 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
